Ovarian cancer stem cells (CSCs) were found to exhibit lower surface expression of MHC-class I, intercellular adhesion molecule 1 (ICAM-1 or CD54), and programmed death-ligand 1 (PD-L1) receptors, while exhibiting higher expression of CD44 [23]. This evidence concerns the gene ICAM1 and ovarian carcinoma.